Adage Capital Partners Gp, L.L.C. Cytokinetics Inc Transaction History

Adage Capital Partners Gp, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $478,125 - $810,450	7,500 Added 25.0%	37,500 $2.63 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $806,400 - $2.5 Million	30,000 New	30,000 $2.5 Million
Q3 2021 Nov 15, 2021	SELL	$18.54 - $35.74 $13.2 Million - $25.4 Million	-711,407 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$19.79 - $26.99 $16.6 Million - $22.6 Million	-838,593 Reduced 54.1%	711,407 $14.1 Million
Q1 2021 May 17, 2021	BUY	$18.57 - $25.68 $28.8 Million - $39.8 Million	1,550,000 New	1,550,000 $36.1 Million

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.9B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.